Ocugen is a clinical-stage biopharmaceutical company that develops gene therapies to cure blindness diseases. Their pipeline includes gene therapy products for inherited retinal diseases, dry age-related macular degeneration, and diabetic macular edema. They have partnerships with CanSino Biologics and Bharat Biotech. The company is based in Malvern, Pennsylvania.